Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 1;52(8):758-769.
doi: 10.3899/jrheum.2024-1218.

Experiences With Complementary and Integrative Health Among People With Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Qualitative Study

Affiliations

Experiences With Complementary and Integrative Health Among People With Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Qualitative Study

Sarah L Patterson et al. J Rheumatol. .

Abstract

Objective: Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are chronic immune-mediated inflammatory diseases often complicated by persistent pain and fatigue, despite cutting-edge pharmacological treatments. Lifestyle medicine (LM) and complementary and integrative health (CIH) offer adjuvant therapies with the potential to alleviate these symptoms, but little is known about patients' experiences with these modalities.

Methods: This qualitative study explored the use of LM and CIH among English- and Spanish-speaking patients with RA and SLE. We conducted 5 focus groups using an original semistructured interview guide to examine participants' experiences with, and barriers to using, LM and CIH. Group discussions were recorded, transcribed verbatim, translated, and analyzed in a multistep iterative process to identify frequencies and thematic trends.

Results: Thirty-nine participants with RA or SLE discussed using LM and CIH modalities to manage their disease in 130 mentions. Diet was the most frequently discussed LM modality, with participants noting specific foods that exacerbated or alleviated symptoms. Traditional Chinese medicine and natural products were the most-discussed CIH approaches, and participants expressed a strong interest in exploring additional CIH modalities to mitigate symptoms. The primary barriers to using LM and CIH were uncertainty regarding safe and effective practices and high out-of-pocket expenses.

Conclusion: Patients with RA and SLE are highly interested in using LM and CIH to manage their conditions, but many are unsure which adjunctive treatment approaches are safe and effective. More research on LM and CIH modalities is needed to facilitate clear, evidence-based answers to these common patient questions.

Keywords: complementary and integrative health; lifestyle medicine; qualitative research; rheumatoid arthritis; systemic lupus erythematosus.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have no financial disclosures.

Similar articles

References

    1. Scott IC, Ibrahim F, Panayi G, et al. The frequency of remission and low disease activity in patients with rheumatoid arthritis, and their ability to identify people with low disability and normal quality of life. Semin Arthritis Rheum 2019;49:20–6. - PubMed
    1. Ishida M, Kuroiwa Y, Yoshida E, et al. Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review. Mod Rheumatol 2018;28:789–99. - PubMed
    1. Santos EJF, Duarte C, Marques A, et al. Effectiveness of non-pharmacological and non-surgical interventions for rheumatoid arthritis: an umbrella review. JBI Database System Rev Implement Rep 2019;17:1494–531. - PubMed
    1. Schmeding A, Schneider M. Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2013;27:363–75. - PubMed
    1. Abasolo L, Leon L, Rodriguez-Rodriguez L, et al. Safety of disease-modifying antirheumatic drugs and biologic agents for rheumatoid arthritis patients in real-life conditions. Semin Arthritis Rheum 2015;44:506–13. - PubMed

LinkOut - more resources